Multiple risk factors were associated with denials and longer wait times for biologic treatment in moderate to severe asthma, ...

The incidence and prevalence of eosinophilic esophagitis in the United States are higher than previously reported, indicating increased disease burden, according to a poster presented here. EoE can ...

Harms of race-specific lung function calculations extend to asthma and treatment, particularly in Black children.

Treating babies with antibiotics produce short-term microbiome changes that raise their risk for childhood asthma.

SAN DIEGO -- A research tool more often used in dermatology that monitors water loss from skin may help allergists stop an ...

In a poster presentation, Marc A. Riedl, M.D., M.S. also shared that at the time of data cut-off the median proportion of days with symptoms in deucrictibant-treated participants in the OLE was zero ...

MONDAY, March 3, 2025 (HealthDay News) — Omalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumption (DC) of allergy-triggering foods after ...

and Immunology (AAAAI) Annual Meeting in San Diego. The company’s proprietary Digital Immune Optimized Synthetic Vaccine (DIOSynVax) platform uses artificial intelligence to create safer and stronger ...

CDX-622 inhibits SCF and TSLP-dependent inflammatory signatures in human skin -- Phase 1 study in healthy volunteers ongoing -HAMPTON, N.J., ...

Therapeutics announced positive preclinical data from CDX-622, a novel bispecific antibody that targets two non-redundant, ...

KalVista Pharmaceuticals, Inc. today announced the presentation of novel sebetralstat data related to laryngeal hereditary angioedema (HAE) attacks and adolescents with HAE at the American Academy of ...